ARTICLE | Company News
Salix, Pharmatel pty Ltd. sales and marketing update
July 5, 2004 7:00 AM UTC
Pharmatel received marketing rights in Australia and New Zealand to SLXP's Colazal balsalazide to treat mild to moderate ulcerative colitis. In exchange, SLXP received a milestone and has the first r...